Las Vegas—Herpes simplex virus (HSV) keratitis is the leading infectious cause of corneal blindness in the developed world, said Deborah Pavan-Langston, MD, FACS, at the American Academy of Ophthalmology annual meeting. HSV infection also is one of the most complicated illnesses, because it encompasses mechanical and immune as well as infectious components, continued Dr. Pavan-Langston, associate professor of ophthalmology, Harvard Medical School, Boston.
Las Vegas—Omesh P. Gupta, MD, MBA, of Wills Eye at Jefferson, Philadelphia, was named the winner of the fourth annual Ophthalmology Times Resident Writer's Award Program. The program was sponsored by Advanced Medical Optics (AMO). During a presentation in November at the Venetian Hotel, Dr. Gupta was the first-place winner for a case study of intracameral entry of antibiotic ointment following routine cataract phacoemulsification.
A 59-year-old male was referred for decreased vision and glare in his right eye 7 days after uneventful clear corneal (CC) phacoemulsification with IOL implantation. On postoperative day 1, his visual acuity was 20/25 in the affected eye. The anterior chamber reaction revealed 1+ cell and flare and the IOL was clear.
Louisville, KY—Potentia Pharmaceuticals has appointed Armen H. Tashjian Jr., MD, to its scientific advisory board.
Jacksonville, FL—Results of the Herpetic Eye Disease Studies (HEDS) have provided some guidance on the treatment of herpes simplex virus (HSV) keratitis, but questions remain about the management of these infections, said Thomas J. Liesegang, MD.
Seoul, Korea—Intraoperative use of mitomycin-C (MMC) is a safe and effective method for preventing corneal haze in eyes undergoing PRK, said Dongho Lee, MD, PhD, director, Yonsei Eye Center, Seoul, South Korea.
Fort Lauderdale, FL—An analysis of the correlation between macular thickness and visual acuity supports the concept that measurement of structural changes can provide valuable information about the nature of functional changes in the treatment of macular edema, said Julia A. Haller, MD, who spoke during the Association of Research in Vision and Ophthalmology annual meeting.
Irvine, CA—Allergan Inc. has announced the recipients of its first Allergan Horizon Grant Program awards. The company will contribute $1 million over 2 years to academic medical institutions to support fellows conducting clinical research in the diagnosis or pharmacologic treatment of glaucoma and corneal and retinal diseases.
Baltimore—Results of a prospective randomized trial conducted in Ethiopia demonstrated that a single dose of oral azithromycin (Zithromax, Pfizer) after trichiasis surgery safely and significantly reduced trichiasis recurrence compared with a 6-week course of topical treatment with tetracycline ointment, reported Sheila K. West, PhD, and colleagues.
Grand Rapids, MI—Just as the preoperative evaluation of patients about to undergo corneal transplantations involves numerous factors, so does the postoperative management of patients who have undergone these procedures, especially penetrating keratoplasty (PK). David D. Verdier, MD, outlined how to care for these patients with special emphasis on corneal surface problems, which he believes are responsible for a high percentage of graft failures.